Limbal stem cell deficiency can lead to blindness due to the inability to regenerate corneal surface cells, presenting a significant challenge to vision restoration treatments.
The Lancet study in Japan utilizing induced pluripotent stem cells for corneal repair showcased a high success rate with no signs of immune rejection or tumors.
Research indicates that stem cells may stimulate the body's own cells for repair, marking an important advancement in regenerative medicine and the treatment of various conditions.
Recent breakthroughs in stem cell research include potential therapies for type 1 diabetes and neurological regeneration, highlighting the technology's expanding role in healthcare.
Collection
[
|
...
]